BACKGROUND AND PURPOSE: Diaphragm muscle weakness occurs in patients with heart failure (HF) and is associated with exercise intolerance and increased mortality. Reduced sensitivity of diaphragm fibres to calcium contributes to diaphragm weakness in HF. Here we have investigated the ability of the calcium sensitizer levosimendan to restore the reduced calcium sensitivity of diaphragm fibres from rats with HF. EXPERIMENTAL APPROACH: Coronary artery ligation in rats was used as an animal model for HF. Sham-operated rats served as controls. Fifteen weeks after induction of HF or sham operations animals were killed and muscle fibres were isolated from the diaphragm. Diaphragm fibres were skinned and activated with solutions containing incremental calcium concentrations and 10 µM levosimendan or vehicle (0.02% DMSO). Developed force was measured at each calcium concentration, and force-calcium concentration relationships were plotted. KEY RESULTS: Calcium sensitivity of force generation was reduced in diaphragm muscle fibres from HF rats, compared with fibres from control rats (P < 0.01). Maximal force generation was ∼25% lower in HF diaphragm fibres than in control fibres (P < 0.05). Levosimendan significantly increased calcium sensitivity of force generation in diaphragm fibres from HF and control rats, without affecting maximal force generation. CONCLUSIONS AND IMPLICATIONS: Levosimendan enhanced the force generating capacity of diaphragm fibres from HF rats by increasing the sensitivity of force generation to calcium concentration. These results provide strong support for testing the effect of calcium sensitizers on diaphragm muscle weakness in patients with HF.
BACKGROUND AND PURPOSE: Diaphragm muscle weakness occurs in patients with heart failure (HF) and is associated with exercise intolerance and increased mortality. Reduced sensitivity of diaphragm fibres to calcium contributes to diaphragm weakness in HF. Here we have investigated the ability of the calcium sensitizer levosimendan to restore the reduced calcium sensitivity of diaphragm fibres from rats with HF. EXPERIMENTAL APPROACH: Coronary artery ligation in rats was used as an animal model for HF. Sham-operated rats served as controls. Fifteen weeks after induction of HF or sham operations animals were killed and muscle fibres were isolated from the diaphragm. Diaphragm fibres were skinned and activated with solutions containing incremental calcium concentrations and 10 µM levosimendan or vehicle (0.02% DMSO). Developed force was measured at each calcium concentration, and force-calcium concentration relationships were plotted. KEY RESULTS:Calcium sensitivity of force generation was reduced in diaphragm muscle fibres from HF rats, compared with fibres from control rats (P < 0.01). Maximal force generation was ∼25% lower in HF diaphragm fibres than in control fibres (P < 0.05). Levosimendan significantly increased calcium sensitivity of force generation in diaphragm fibres from HF and control rats, without affecting maximal force generation. CONCLUSIONS AND IMPLICATIONS: Levosimendan enhanced the force generating capacity of diaphragm fibres from HF rats by increasing the sensitivity of force generation to calcium concentration. These results provide strong support for testing the effect of calcium sensitizers on diaphragm muscle weakness in patients with HF.
Authors: M S Nieminen; J Akkila; G Hasenfuss; F X Kleber; L A Lehtonen; V Mitrovic; O Nyquist; W J Remme Journal: J Am Coll Cardiol Date: 2000-11-15 Impact factor: 24.094
Authors: H Ukkonen; M Saraste; J Akkila; J Knuuti; M Karanko; H Iida; P Lehikoinen; K Någren; L Lehtonen; L M Voipio-Pulkki Journal: Clin Pharmacol Ther Date: 2000-11 Impact factor: 6.875
Authors: Andrew D Michaels; Barry McKeown; Michael Kostal; Kalpesh T Vakharia; Mark V Jordan; Ivor L Gerber; Elyse Foster; Kanu Chatterjee Journal: Circulation Date: 2005-03-21 Impact factor: 29.690
Authors: Hieronymus W H van Hees; Henricus F M van der Heijden; Coen A C Ottenheijm; Leo M A Heunks; Cindy J C Pigmans; Freek W A Verheugt; Rene M H J Brouwer; P N Richard Dekhuijzen Journal: Am J Physiol Heart Circ Physiol Date: 2007-04-20 Impact factor: 4.733
Authors: T Scott Bowen; Norman Mangner; Sarah Werner; Stefanie Glaser; Yvonne Kullnick; Andrea Schrepper; Torsten Doenst; Andreas Oberbach; Axel Linke; Leif Steil; Gerhard Schuler; Volker Adams Journal: J Appl Physiol (1985) Date: 2014-10-30
Authors: Willem-Jan M Schellekens; Hieronymus W H van Hees; Marianne Linkels; P N Richard Dekhuijzen; Gert Jan Scheffer; Johannes G van der Hoeven; Leo M A Heunks Journal: Crit Care Date: 2015-03-02 Impact factor: 9.097
Authors: Josine M de Winter; Barbara Joureau; Vasco Sequeira; Nigel F Clarke; Jolanda van der Velden; Ger Jm Stienen; Henk Granzier; Alan H Beggs; Coen Ac Ottenheijm Journal: Skelet Muscle Date: 2015-04-28 Impact factor: 4.912
Authors: Lisanne Roesthuis; Hans van der Hoeven; Christer Sinderby; Tim Frenzel; Coen Ottenheijm; Laurent Brochard; Jonne Doorduin; Leo Heunks Journal: Intensive Care Med Date: 2019-10-01 Impact factor: 17.440